Ultrasound Subclavian CannulationNCT05107089
Ultrasound Guided Subclavian Vein Cannulation at Emergency Room
An observational study of Ultrasound Subclavian Cannulation, run by Assiut University.
Trial summary
1. To observe and report the success rate associated with the use of ultrasound for subclavian vein catheterization. 2. To observe and report the type and complications and any constrains associated with this technique. Read more about this study
- Who is it for?
- Ages 18 to 80 years
- Conditions the study is for
- Ultrasound Subclavian Cannulation
- What is being tested?
- Ultrasound
- Type of treatment
- Medical device
- How many people
- 30 participants
- Where
- No sites listed yet
- Study dates
- 1 Nov 2021to 1 Mar 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 80 years
- All sexes
- Adult, Older adult
Study population: Any patient has arrived to the emergency room with sign of hypovolemic shock Or arrested
Who may be able to join
- All patient admitted to emergency room and indicated for central venous catheterization
Who cannot join
- 1. Any contraindication for central vein cannulation as coagulopathy, hemorrhage from target vessel, suspected proximal vascular injury 2- Age below 18 year
Trial locations and contacts
No sites are listed yet.
About this study
Official title: Ultrasound Guided Subclavian Vein Cannulation at Emergency Room , Success Rate and Incidence of Complications
- To observe and report the success rate associated with the use of ultrasound for subclavian vein catheterization.
- To observe and report the type and complications and any constrains associated with this technique.
Read the detailed description
Central venous catheterisation is a commonly performed procedure in anaesthesia, critical care, acute and emergency medicine. 1 , the subclavian vein (SCV) has been an important vessel for central venous cannulation.2 The SCV cannulation offers several advantages when compared to the common alternative sites for central venous access. These advantages may include fewer cases of thrombosis, infectious complications, better patient comfort, and increased ability to remain patent in hypovolemic states.3-4 Traditionally, subclavian venous catheterisation has been performed using the landmark technique and because of the complications associated with this technique, it is not commonly performed.1 the complications such as catheter malposition, arterial puncture, hematoma, pneumothorax, hemothorax, and nerve injury.
- Conditions
- Ultrasound Subclavian Cannulation
- Being tested
- Ultrasound
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
UltrasoundDevice
Use of ultrasound at subclavian vein cannulation for visualization
What is being measured
The primary outcome is the main question the study is designed to answer.
success rate of the ultrasound guided subclavian vein cannulation success rate of the ultrasound guided subclavian vein cannulation Success rate of ultrasound guided of subclavian vein cannulation
Use of ultrasound at visualization of cannulation of subclavian vein
Measured: Baseline
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted4 Nov 2021
- Study start1 Nov 2021 (estimated)
- Primary completion1 Nov 2024 (estimated)
- Study completion1 Mar 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Ultrasound Subclavian CannulationStudies of the same condition, open and under way.
- More trials run by Assiut UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Prospective
- Enrolment
- 30 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Assiut University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, ARMohamed, Assiut University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05107089
- Sponsor's protocol ID
- Subclavian vein cannulation
- Status last verified
- Oct 2021
- First submitted
- 25 Oct 2021
- Last updated
- 4 Nov 2021
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Hayashi M, Oshima K. Purification and properties of oxytocinase (cystine amino-peptidase) from monkey placenta. J Biochem. 1976 Aug;80(2):389-96. doi: 10.1093/oxfordjournals.jbchem.a131288.
PubMed 12146
Study at a glance
From the registry record, last updated by the sponsor on 4 Nov 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Ultrasound Guided Subclavian Vein Cannulation at Emergency Room , Success Rate and Incidence of Complications
- ClinicalTrials.gov ID
- NCT05107089
- Acronym / sponsor ID
- Subclavian vein cannulation
- Conditions
- Ultrasound Subclavian Cannulation
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 30 participants (estimated)
- Lead sponsor
- Assiut UniversityUniversity, hospital or other
- Study start
- 1 Nov 2021 (estimated)
- Primary completion
- 1 Nov 2024 (estimated)
- Study completion
- 1 Mar 2025 (estimated)
- First posted
- 4 Nov 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
- To observe and report the success rate associated with the use of ultrasound for subclavian vein catheterization.
- To observe and report the type and complications and any constrains associated with this technique.
Detailed description
Central venous catheterisation is a commonly performed procedure in anaesthesia, critical care, acute and emergency medicine. 1 , the subclavian vein (SCV) has been an important vessel for central venous cannulation.2 The SCV cannulation offers several advantages when compared to the common alternative sites for central venous access. These advantages may include fewer cases of thrombosis, infectious complications, better patient comfort, and increased ability to remain patent in hypovolemic states.3-4 Traditionally, subclavian venous catheterisation has been performed using the landmark technique and because of the complications associated with this technique, it is not commonly performed.1 the complications such as catheter malposition, arterial puncture, hematoma, pneumothorax, hemothorax, and nerve injury.
Study design
- Observational model
- Other
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 to 80 years
- Sex
- All
- Age groups
- Adult, Older adult
- Study population
- Any patient has arrived to the emergency room with sign of hypovolemic shock Or arrested
Key inclusion criteria (1 listed)
- All patient admitted to emergency room and indicated for central venous catheterization
Key exclusion criteria (1 listed)
- 1. Any contraindication for central vein cannulation as coagulopathy, hemorrhage from target vessel, suspected proximal vascular injury 2- Age below 18 year
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| UltrasoundUse of ultrasound at subclavian vein cannulation for visualization | Device | – |
Primary outcome
success rate of the ultrasound guided subclavian vein cannulation success rate of the ultrasound guided subclavian vein cannulation Success rate of ultrasound guided of subclavian vein cannulation
Time frame: Baseline
Use of ultrasound at visualization of cannulation of subclavian vein
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 Nov 2021.
- Background: PubMed 12146Hayashi M, Oshima K. Purification and properties of oxytocinase (cystine amino-peptidase) from monkey placenta. J Biochem. 1976 Aug;80(2):389-96. doi: 10.1093/oxfordjournals.jbchem.a131288.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Questions about this trial
What is this clinical trial studying?
An observational study of Ultrasound Subclavian Cannulation, run by Assiut University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 4 Nov 2021. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Alshaima R Mohamed, Resident (+2 01001960463, Shaimarefai@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
success rate of the ultrasound guided subclavian vein cannulation success rate of the ultrasound guided subclavian vein cannulation Success rate of ultrasound guided of subclavian vein cannulation (time frame: Baseline). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05107089, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Nov 2021.